Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Pain management after total hip arthroplasty at five different Danish hospitals: A prospective, observational cohort study of 501 patients

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Cardiac arrhythmias in critically ill patients with coronavirus disease 2019: a retrospective population-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Inflammatory response, fluid balance and outcome in emergency high-risk abdominal surgery

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Pre-operative epidural analgesia in hip fracture patients - A systematic review and meta-analysis

    Research output: Contribution to journalReviewpeer-review

  4. Training non-intensivist doctors to work with COVID-19 patients in intensive care units

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: The available literature does not present a "gold standard" for post-operative pain treatment after total hip arthroplasty (THA). The aim of this prospective observational study was to explore and document post-operative pain treatment, including outcomes, in a large cohort of patients undergoing THA at five different Danish hospitals.

METHODS: This prospective, multicentre, observational cohort study of 501 THA patients was performed at five different hospitals in the Capital Region and at the Region Zealand in Denmark, from April 2014 to April 2016. The study had two co-primary outcomes: Pain during mobilisation at 6 hours post-operatively (numeric rating scale [NRS] [0-10]) and morphine consumption 0-24 hours post-operatively.

RESULTS: A large variety of analgesic treatments were used at the included hospitals and none of the hospitals used the same non-opioid basic analgesic regimen. For all patients at all hospitals, the NRS-pain level during mobilisation at 6 hours was 5 (3-6), (median [interquartile range]) and the 24-hour intravenous morphine (eqv) consumption was 25 mg (18-35). Although some statistically significant differences between hospitals were found for morphine use, no non-opioid analgesic regimen demonstrated consistent clinically relevant superior efficacy. In general, pain levels at rest were low to moderate and pain during mobilisation was moderate.

CONCLUSIONS: Analgesic treatment routines differed between hospitals. Pain levels, however, did not differ substantially and were in general low at rest and moderate during mobilisation. No non-opioid analgesic treatment demonstrated consistent analgesic superiority.

Original languageEnglish
JournalActa Anaesthesiologica Scandinavica
Volume63
Issue number7
Pages (from-to)923-930
Number of pages8
ISSN0001-5172
DOIs
Publication statusPublished - 2019

    Research areas

  • analgesics, arthroplasty, hip, pain, postoperative, replacement

ID: 57585328